Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral morphine drops for dyspnea in terminal lung cancer patients
2005-004831-23Phase 3Completed
- Sponsor
- Sankt Lukas Hospice
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of morphine in Dyspnoea (SOB) (2 arms), sponsored by Sankt Lukas Hospice. Primary endpoints: Time to minimal noticeable relief of dyspnea and Dyspnea visual analogue scale over time. Started Jan 2006; status: completed.
02
Drugs
morphine
03
Conditions
Dyspnoea (SOB)
Beyond the preview
Go deeper on 2005-004831-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004831-23.